Description

CagriSema Peptide for Advanced Dual Amylin and GLP-1 Receptor Research

CagriSema Peptide is a fixed-dose research co-formulation that combines Cagrilintide, a long-acting amylin receptor agonist, with Semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. This dual-peptide platform enables researchers to investigate the coordinated activation of complementary endocrine signaling pathways involved in metabolic regulation, receptor pharmacology, and neuroendocrine communication.

Scientific investigations utilize CagriSema across molecular endocrinology, receptor biology, peptide pharmacology, neuroscience, and metabolic research. Laboratory studies commonly examine receptor crosstalk between amylin receptor complexes and GLP-1 receptors, intracellular second messenger signaling, peptide-receptor dynamics, neuronal activation, hormone signaling, and integrated metabolic network regulation.

Researchers continue to investigate molecular interactions involving receptor trafficking, cyclic AMP signaling, calcium mobilization, protein kinase activation, transcriptional regulation, and central nervous system pathways associated with energy homeostasis. Because both peptide components possess extended pharmacokinetic properties, CagriSema is particularly valuable for studies requiring prolonged receptor engagement and sustained intracellular signaling.

Each batch is manufactured under rigorous quality-controlled procedures, analytically verified for purity and structural identity, and supplied as a stable lyophilized research formulation accompanied by a comprehensive Certificate of Analysis to ensure reproducible laboratory performance.

For research use only. Not intended for human consumption or clinical use.

Key Research Highlights

• Fixed-dose co-formulation of Cagrilintide and Semaglutide
• Dual activation of amylin and GLP-1 receptor pathways
• Extensively investigated in metabolic signaling research
• Frequently utilized in receptor crosstalk investigations
• Evaluated in neuroendocrine communication studies
• Studied in intracellular cAMP and calcium signaling pathways
• Applied in peptide pharmacology and molecular endocrinology
• High-purity lyophilized research formulation
• Certificate of Analysis (COA) supplied with every batch
• Manufactured under stringent analytical quality standards
• Excellent batch-to-batch reproducibility
• Suitable for biotechnology, pharmaceutical, and academic research laboratories

Why Researchers Choose This Product

• ≥99% research-grade purity verified through analytical testing
• Verified dual-peptide formulation and structural integrity
• Extended receptor engagement suitable for laboratory investigations
• Stable lyophilized formulation for long-term storage
• Comprehensive Certificate of Analysis included
• Reliable reproducibility across experimental studies
• Suitable for endocrinology and receptor pharmacology research
• Manufactured using rigorous peptide production standards
• Excellent analytical consistency between production batches
• Intended exclusively for scientific laboratory investigations

Research Applications

Dual Receptor Pharmacology

CagriSema Peptide is extensively utilized in laboratory investigations examining coordinated activation of amylin receptor complexes and glucagon-like peptide-1 (GLP-1) receptors, receptor signaling integration, and pharmacodynamic interactions.

Molecular Endocrinology

Researchers employ CagriSema to investigate endocrine signaling pathways, hormone communication networks, receptor trafficking, intracellular messenger systems, and peptide-mediated regulation.

Metabolic Signaling Research

Experimental models utilize CagriSema to evaluate intracellular signaling involving cAMP production, protein kinase activation, calcium mobilization, metabolic transcription factors, and receptor-mediated cellular responses.

Neuroendocrine Biology

Scientists investigate hypothalamic signaling, brainstem neuronal communication, neuropeptide regulation, receptor distribution, and mechanisms governing central endocrine integration.

Receptor Biology

Laboratory investigations incorporate CagriSema into studies examining ligand binding kinetics, receptor internalization, receptor activity-modifying proteins, and structure-function relationships of peptide hormones.

Peptide Pharmacology

Researchers utilize CagriSema for analytical characterization, peptide stability studies, formulation development, pharmacokinetic investigations, and molecular interaction analyses.

Product Specifications

Mechanism of Action

CagriSema Peptide is a dual-hormone research formulation composed of Cagrilintide, a long-acting amylin analog, and Semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The co-formulation is designed to facilitate laboratory investigations of complementary endocrine signaling pathways that regulate metabolic communication, receptor pharmacology, and neuroendocrine integration. Each peptide activates distinct receptor systems while converging on interconnected intracellular signaling networks, making CagriSema an important research tool for studying coordinated peptide hormone biology.

The Cagrilintide component primarily activates amylin receptor (AMYR) complexes composed of the calcitonin receptor (CTR) associated with receptor activity-modifying proteins (RAMPs). Activation of these receptors stimulates Gs protein-mediated adenylyl cyclase, increasing intracellular cyclic AMP (cAMP) concentrations and activating downstream protein kinase A (PKA) and CREB signaling. Researchers investigate these pathways in studies involving neuronal communication, receptor trafficking, calcium signaling, and endocrine regulation.

The Semaglutide component selectively activates the GLP-1 receptor (GLP-1R), another Class B G protein-coupled receptor. GLP-1 receptor activation similarly stimulates cAMP production while engaging additional signaling pathways including PI3K/Akt, MAPK/ERK, Epac2, and calcium-dependent intracellular mechanisms. Laboratory studies examine these pathways to understand receptor-mediated transcriptional regulation, cellular communication, and peptide signaling dynamics.

Because both receptor systems utilize complementary intracellular signaling cascades, researchers investigate potential receptor crosstalk, coordinated second messenger responses, and integrated neuroendocrine signaling within hypothalamic and brainstem neuronal networks. Experimental investigations also explore receptor internalization, ligand-receptor kinetics, peptide stability, pharmacodynamic interactions, and prolonged receptor engagement resulting from the extended half-life characteristics of both peptide components.

The defined molecular composition, reproducible analytical profile, and dual-receptor pharmacology of CagriSema Peptide make it a valuable research reagent for molecular endocrinology, receptor biology, peptide pharmacology, neuroscience, biotechnology, and life science laboratories investigating integrated hormone signaling and cellular communication.

For research use only. Not intended for human consumption or clinical use.